List Alan
SEC insider (Form 3/4/5 filer). CIK 0001858530. Director at TuHURA Biosciences, Inc./NV (HURA). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in TAMPA, FL.
Companies List Alan has filed insider reports for
- TuHURA Biosciences, Inc./NV (HURA): Director
List Alan
CIK: 0001858530
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TuHURA Biosciences, Inc./NV
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 12, 2026HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
156.2K shares- - Jan 2, 2025HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
51.3K shares- - Oct 18, 2024KTRA
Kintara Therapeutics, Inc.
AwardDirectOptions (Right to Buy)
13.6K shares- - Oct 18, 2024KTRA
Kintara Therapeutics, Inc.
AwardDirectOptions (Right to Buy)
13.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | HURA TuHURA Biosciences, Inc./NV | Award Options (Right to Buy) | 156,240 | - | - | Direct |
| Jan 2, 2025 | HURA TuHURA Biosciences, Inc./NV | Award Options (Right to Buy) | 51,275 | - | - | Direct |
| Oct 18, 2024 |  KTRA Kintara Therapeutics, Inc. | Award Options (Right to Buy) | 13,553 | - | - | Direct |
| Oct 18, 2024 | KTRA Kintara Therapeutics, Inc. | Award Options (Right to Buy) | 13,553 | - | - | Direct |
1-4 of 4 transactions